What does Wayland Group Corp. do?

Wayland Group Corp. (MRRCF) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is MRRCF's market cap?

Wayland Group Corp. (MRRCF) has a market capitalization of approximately $2,121, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does MRRCF pay a dividend?

No — Wayland Group Corp. (MRRCF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Wayland Group Corp. (MRRCF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

MRRCF

Wayland Group Corp.

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.00$0.00+0.00%

Market cap$2.12K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.75%CAGR −69.83%

Select date range

FromTo

May 4, 2001Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

MRRCF does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateNov 28

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how MRRCF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MRRCF and 80,000+ other tickers.

About Wayland Group Corp.

Wayland Group Corp. specializes in the cultivation and sale of both medical and recreational cannabis products, serving patients and consumers across Canada and on the international stage. Their product portfolio encompasses a diverse selection of cannabis strains, featuring varying levels of CBD, balanced cannabinoid profiles, and high THC content. These are marketed under several distinct brands, including Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann. Established in 2013, the company maintains its headquarters in Oakville, Canada, and operates as a subsidiary of Maricann Group Inc.

CEO: David Miller
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: OTC
Employees: 68
Website: www.waylandgroup.com

Peers

Peers Tab

ATTBF

Abattis Bioceuticals Corp.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About MRRCF

What does Wayland Group Corp. do?: Wayland Group Corp. (MRRCF) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is MRRCF's market cap?: Wayland Group Corp. (MRRCF) has a market capitalization of approximately $2,121, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does MRRCF pay a dividend?: No — Wayland Group Corp. (MRRCF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is MRRCF profitable?: Wayland Group Corp. (MRRCF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.